Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for healthcare industry professionals · Thursday, April 18, 2024 · 704,540,016 Articles · 3+ Million Readers

US Substance Use Disorder Treatment Market Exhibits 7.1% CAGR to Reach USD 60.18 Billion by 2029

As per the report by Fortune Business Insights, the global US Substance Use Disorder Treatment Market size is projected to reach USD 60.18 Billion in 2029, at a CAGR of 7.1% during the forecast period, 2022-2029

/EIN News/ -- Pune, India, Feb. 20, 2023 (GLOBE NEWSWIRE) -- The US substance use disorder treatment market size was USD 35.14 billion in 2021 and is expected to grow from USD 37.24 billion in 2022 to USD 60.18 billion by 2029, with a CAGR of 7.1% during the forecast period. Substance abuse refers to the condition where uncontrolled use of substances leads to addiction. Rising number of patients seeking assistance for disorder treatment is set to propel market growth. Fortune Business Insights™ shares this information in its report titled “US substance use disorder treatment market, 2022-2029.”

Key Industry Development

July 2022- ERP Health LLC collaborated with Regard Recovery and its subsidiary JourneyPure, with the aim to provide their Outcome Tracking Platform (OTP) services to all JourneyPure patients across 17 facility networks.


Get a Free Sample PDF of the Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/u-s-substance-use-disorder-treatment-market-107172


Report Scope:

Report Coverage Details
Forecast Period 2022 to 2029
Forecast Period 2022 to 2029 CAGR 7.1%
2029 Value Projection 60.18 Billion
Base Year 2021
Market Size in 2021 USD 35.14 Billion
Historical Data 2018 to 2020
No. of Pages 81


Key Takeaways:

  • The market is expected to experience growth as a result of players collaborating to expand the reach of their programs.
  • The opioid addiction treatment segment is anticipated to witness substantial growth during the forecast period.
  • Market players' ongoing development of technologically advanced treatments is a key factor contributing to the growth of the substance use disorder treatment market.

Drivers and Restraints:

Rising Cases of Neurological and Psychological Disorders to Progress Market Development

Rising cases of neurological and psychological disorders such as depression, schizophrenia, sudden mood swings, irritability, and personality disorders, are anticipated to drive the US substance use disorder treatment market growth. In September 2021, the Freedom Center Outpatient Recovery Center stated that schizophrenia affects around 1.5 million people in the U.S. annually. Number of people falling victim to substance abuse at a young age contributes to an increase in admissions to substance abuse treatment facilities. Rising penetration of insurance coverage for the treatment of substance abuse is also expected to drive market growth.
However, delay in the diagnosis of substance abuse is expected to hamper the market growth.


Browse Complete Report Details: https://www.fortunebusinessinsights.com/u-s-substance-use-disorder-treatment-market-107172


Segments:

Level 2 Care to Lead as it Helps in Relapse Management

Based on the level of care, the market is divided into early intervention, level 1/outpatient services, level 2, level 3, and level 4/medically managed intensive inpatient services. Level 2 segment is set to account for the highest share of the segment as it enables patients to continue with their normal, day-to-day activities, and assist in relapse management. Level1/outpatient services are expected to have highest CAGR due to the rising focus of substance use disorder treatment providers on expanding their outpatient services.

Rising Number of Illicit Drug Users to Accelerate Opportunities for the Drug Abuse Treatment Providers
Based on application, the market is categorized into alcohol addiction treatment, drug abuse treatment, nicotine addiction treatment, and opioid addiction treatment. Drug abuse treatment is anticipated to dominate the market due to increase in the number of illicit drug users in the U.S. The alcohol addiction treatment segment has the highest CAGR due to increasing number of people involved in alcohol abuse.

Adult Segment to Govern Owing to Growing Number of Patient Admissions

According to age group, the market is bifurcated into adult and adolescent. The adult segment is projected to govern due to increased inpatient admissions to hospitals and substance abuse treatment centers. The adolescent segment is expected to grow at the highest CAGR owing to the rise in incidents of children getting involved in alcohol consumption or use of any illicit drug at an early stage.

Hospitals and Specialty Clinics to Govern they Help in Alcohol Abuse

According to service provider, the market is segmented into rehabilitation centers, hospitals and specialty clinics, sober living homes, and others in terms of service provider. Hospitals and specialty clinics segment is projected to dominate due to increasing number of patient visits to hospitals treating patients involved in alcohol and other substance use disorders.


Access Full Report: https://www.fortunebusinessinsights.com/checkout-page/107172


Competitive Landscape:

New Substance-Use Treatment Programs by Key Players to Progress Market Track

The US substance use disorder treatment market share is featured by players such as Hazelden Betty Ford Foundation, Pyramid Healthcare Inc., and Acadia Healthcare. The players have been focused on introducing new substance-use treatment programs. In July 2022, Acadia Healthcare formed a joint venture with ECU Health to build a 144-bed inpatient behavioral health hospital in Greenville medical district. The market is also characterized by residential and outpatient facility providers focused on providing behavioral treatment facilities and different reprocessing therapies.  

List of Key Players Profiled in the Report:

  • Hazelden Betty Ford Foundation (U.S.)
  • JourneyPure (Regard Recovery) (U.S.)
  • Workit Health (U.S.)
  • Pyramid Healthcare Inc. (U.S.)
  • American Treatment Network (U.S.)
  • Banyan Treatment Centers (U.S.)
  • Asana Recovery (U.S.)
  • Acadia Healthcare (U.S.)
  • Promises Behavioral Health (U.S.)


FAQs:

How big is the US Substance Use Disorder Treatment Market?

The market is projected to grow from USD 37.24 billion in 2022 to USD 60.18 billion by 2029, exhibiting a CAGR of 7.1% during the forecast period.


Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/u-s-substance-use-disorder-treatment-market-107172

 

Major Table of Contents:

  • Introduction
    • Research Scope
    • Market Segmentation
    • Research Methodology
    • Definitions and Assumptions
  • Executive Summary
  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
    • Market Trends
  • Key Insights
    • Prevalence of Substance Abuse in U.S., 2021
    • Overview of Advances in Novel Therapeutics
    • Overview of Harm Reduction Vs Abstinence-based Recovery Model
    • Overview on Concierge Medicine in U.S.
    • Impact of COVID 19 Pandemic on the Market
  • U.S. Substance Abuse Treatment Market Analysis, Insights and Forecast, 2018-2029
    • Market Analysis, Insights and Forecast – By Level of Care
      • Early Intervention
      • Level 1/Outpatient Services
      • Level 2
        • Intensive Outpatient Services
        • Partial Hospitalization Services
      • Level 3
        • Clinically Managed Low-Intensity Residential Services
        • Clinically Managed Medium-Intensity Residential Services
        • Clinically Managed High-Intensity Residential Services
        • Medically Monitored High-Intensity Inpatient Services
  • Competitive Analysis
    • Market Analysis, Insights and Forecast – By Application
      • Alcohol Addiction Treatment
      • Drug Abuse Treatment
      • Nicotine Addiction Treatment
      • Opioid Addiction Treatment
    • Market Analysis, Insights and Forecast – By Age Group
      • Adult
      • Adolescent
    • Market Analysis, Insights and Forecast – By Service Provider
      • Rehabilitation Centers
      • Hospitals and Specialty Clinics
      • Sober Living Homes
      • Others
    • Market Analysis, Insights and Forecast – By Geography
      • Northeast
      • West
      • South
      • Midwest
      • Other U.S. Territories
      • Level 4/Medically Managed Intensive Inpatient Services
    • Company Profiles (Overview, Products & Services, SWOT analysis, Recent Developments, Strategies, Financials (based on availability))
      • Hazelden Betty Ford
      • JourneyPure
      • Workit Health
      • Pyramid Healthcare Inc.
      • American Treatment Network
      • Banyan Treatment Centers
      • Asana Recovery
      • Acadia Healthcare
      • Promises Behavioral Health
      • Passage Malibu


Ask for Customization of this Report: https://www.fortunebusinessinsights.com/enquiry/ask-for-customization/u-s-substance-use-disorder-treatment-market-107172


Related Reports:

U.S. Behavioral Health Market Share, Industry Report 2029

Telerehabilitation Market Revenue Growth Forecast to 2029

Opioid Use Disorder (OUD) Market Size, Share, Revenue Forecast and Opportunities

Outpatient Rehabilitation Centers Market Size, Share, and Industry Report

Nicotine Replacement Therapy (NRT) Market Size, Growth Forecast and Opportunities

Nicotine De-Addiction Products Market Size, Share, Opportunities, Revenue and Outlook

Addiction Treatment Market Size, Share, Revenue And Growth Rate Till 2028

About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.

US: +1 424 253 0390

UK: +44 2071 939123

APAC: +91 744 740 1245

Email: sales@fortunebusinessinsights.com


Primary Logo

Powered by EIN News


EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.

Submit your press release